Comparative Study between the Effect of Dexmedetomidine versus Nalbuphine as an Adjuvant to Bupivacaine in Paravertebral Block in Breast Cancer Surger
Not Applicable
- Conditions
- CancerSurgerybreast cancer
- Registration Number
- PACTR201710002161189
- Lead Sponsor
- Faculty of Medicine Fayoum University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
ASA I, II, III
female 18-78
breast cancer surgery
Exclusion Criteria
Exclusion criteria included patients undergoing bilateral breast surgery or breast reconstruction; those having contra-indications for PVB, e.g., patient refusal, infection at injection site, anticoagulant therapy, abnormal coagulation profile, or hypersensitivity to LA; patients on chronic antiemetics or chronic pain medication; pregnant patients; central neuropathy, liver or renal impairment, drug or alcohol abusers, and those with psychiatric illnesses that would interfere with perception and assessment of pain and obese patients with a body mass index (BMI) >30 kg/m2.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method